American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,060 | 64,871 | 55,200 | 61,872 | 69,403 |
| Receivables | 107,547 | 99,320 | 99,526 | 95,902 | 96,221 |
| Inventories | 7,249 | 6,931 | 11,433 | 6,382 | 6,535 |
| Other current assets | 14,513 | 524 | 577 | 0 | 0 |
| TOTAL | $230,079 | $198,134 | $194,863 | $184,764 | $192,497 |
| Non-Current Assets | |||||
| PPE Net | 161,281 | 179,979 | 180,268 | 168,346 | 167,621 |
| Intangibles | 603,149 | 602,928 | 595,967 | 595,755 | 595,912 |
| Other Non-Current Assets | 152,914 | 153,136 | 14,745 | 18,198 | 19,639 |
| TOTAL | $917,344 | $936,043 | $790,980 | $782,299 | $783,172 |
| Total Assets | $1,147,423 | $1,134,177 | $985,843 | $967,063 | $975,669 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 44,415 | 46,553 | 42,855 | 47,206 | 46,660 |
| Accounts payable and accrued liabilities | 57,648 | 46,415 | 59,082 | 54,023 | 52,849 |
| Accrued Expenses | 98,293 | 94,479 | 95,703 | 77,811 | 79,842 |
| TOTAL | $222,613 | $209,285 | $197,640 | $179,040 | $179,351 |
| Non-Current Liabilities | |||||
| Long Term Debt | 567,296 | 548,409 | 517,511 | 506,750 | 509,983 |
| Other Non-Current Liabilities | 252,898 | 265,961 | 145,866 | 170,760 | 170,080 |
| TOTAL | $836,057 | $822,602 | $678,292 | $695,599 | $700,035 |
| Total Liabilities | $1,058,670 | $1,031,887 | $875,932 | $874,639 | $879,386 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,564 | 32,564 | 32,564 | 32,517 | 32,467 |
| Common Shares | 197 | 197 | 196 | 195 | 195 |
| Retained earnings | -183,108 | -174,930 | -164,451 | -140,003 | -142,493 |
| Other shareholders' equity | 168,382 | 172,622 | 168,451 | 166,267 | 169,411 |
| TOTAL | $88,753 | $102,290 | $109,911 | $92,424 | $96,283 |
| Total Liabilities And Equity | $1,147,423 | $1,134,177 | $985,843 | $967,063 | $975,669 |